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Abstract
Background: The objective for this present study was to determine whether or not suspension
bead array is a feasible method to detect changes in cytokine protein expression in mouse lung
tissue homogenates. Here, we report on suspension bead array as a feasible method for detection
of lipopolysaccharide (LPS)-evoked changes in cytokine protein expression in mouse lung tissue
homogenates.
Materials and methods: Mice were treated (0.2 ml, intraperitoneal, i.p.) with phosphate buffered
saline (PBS) or LPS (0.25 mg/ml) and sacrificed at either 2- or 24-hours post treatment. Formalin-
fixed and paraffin-embedded lung sections were evaluated by light microscopy. Flash frozen lung
tissues were homogenized for measurement of various cytokine protein expression levels using
suspension bead array, antibody array and ELISA. Comparison between groups was performed
using a Wilcoxon signed rank test.
Results: Pulmonary perivascular edema and an accumulation of mixed cell infiltrates within blood
and lymphatic vessels, as well as in the adjacent interstitium, were present at both 2- and 24-hours
following LPS treatment. A minimal increase in the number of alveolar macrophages was also
observed in the 24-hour LPS-treated mice only. The suspension bead array assay revealed
statistically significant increases in mouse lung tissue homogenate levels of interleukin-6 (IL-6) and
granulocyte/macrophage colony-stimulating factor (GM-CSF) proteins and a decrease in IL-2
protein at 24-hours post LPS-treatment only. Similar cytokine protein expression patterns were
observed using antibody array. Significantly increased IL-6 protein expression levels were also
detected using ELISA, which correlated with the suspension bead array data.
Conclusion: The present study shows that suspension bead array is a feasible method to detect
changes in cytokine protein expression in mouse lung tissue homogenates.
Background
The chemically purified endotoxin, lipopolysaccharide
(LPS) has no or only traces amounts of cell wall proteins
[1]. Alveolar macrophages have a primary role in mediat-
ing the effects of LPS entering airways and lungs. CD-1
mice are relatively sensitive to LPS treatment [2,3]. Previ-
ous reports suggested that similar to that seen with sys-
temic inflammatory response in CD-1 mice, pro-
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phage inflammatory protein-2 (MIP-2) protein levels in
mouse lung tissue homogenates are increased following
LPS treatment as determined by ELISA [2]. Increased neu-
trophil infiltration is also detectable in lung sections in
parallel with increased IL-6 and MIP-2 expression in lung
tissue homogenates from LPS-treated mice. Additional
studies are needed to further elucidate diagnostic markers
indicative of the LPS-evoked lung inflammatory injury
response.
While, traditional immunohistochemical staining meth-
ods for detection of cytokine protein expression in tissue
sections is semi-quantitative, current and emerging quan-
titative methods and their applications including the use
of tissue homogenates have been reviewed [3]. Suspen-
sion bead array affords multiplexing of microspheres
labeled with fluorescent dyes and contain surface carboxyl
groups for covalent attachment analytes (i.e., cytokine
proteins) to conform a solid phase sandwich immu-
noassay for measuring multiple analytes simultaneously.
We determined in our laboratory that suspension bead
array is a useful tool for measuring mouse plasma levels of
cytokine protein expression following LPS treatment [4].
In LPS-treated female CD-1 mice, increased plasma levels
of IL-6, interleukin-10 (IL-10), interferonγ (IFNγ) and
tumor necrosis factorα (TNFα) were detectable at both 2-
hours and 24-hours post treatment; while increased
plasma protein levels of interleukin-1β (IL-1β), inter-
leukin-5 (IL-5), interleukin-12 (IL-12) and granulocyte/
macrophage colony-stimulating factor (GM-CSF) were
detectable at 24-hours post-treatment only. Whether or
not suspension bead array can be used to measure mouse
lung tissue homogenate levels of cytokine protein expres-
sion has not been reported in the literature. Procedures for
simultaneous measurement of multiple cytokines in rat
serum and brain tissue by suspension bead array have
been optimized [5,6]. Methods for antibody array analysis
of peripheral and blood cytokine levels in rats after mas-
seter inflammation induced by injection of complete Fre-
und's adjuvant have also been described [7].
The objective for this present study was to determine
whether or not suspension bead array is a feasible method
to detect changes in cytokine protein expression in mouse
lung tissue homogenates.
The feasibility of simultaneous measurement of cytokine
levels may lend to the elucidation of potential diagnostic




Six to eight-week-old female CD-1 mice were purchased
from Charles River Laboratories (Wilmington, MA). Ani-
mals were housed in accordance with the current guide-
lines for animal welfare (Guide for the Care and Use of
Laboratory Animals, 1996, Animal Welfare Act, 1996, as
amended in 1970, 1976 and 1985, 9 CFR Parts 1,2,3).
The following materials were used: lipopolysaccharide
(LPS, Sigma, St. Louis, MO, USA, L2630); phosphate buff-
ered saline (PBS, Sigma); Tissue Protein Extraction reagent
(T-PER, Pierce, Rockford, IL, USA); Complete Mini Pro-
tease Inhibitor Cocktail tablets (Roche Diagnostics, Indi-
anapolis, IN, USA); bicinchoninic acid (BCA) kit (Pierce);
Mouse Cytokine 10-Plex kit, Biosource International,
Camarillo, CA, USA); RayBio Mouse Cytokine Antibody
Array kit (Panomics, Redwood City, CA, USA); enhanced
chemiluminescence (ECL) kit (Amersham Pharmacia Bio-
tech, Piscataway, NJ, USA); X-OMAT AR film (Amersham
Pharmacia Biotech); and mouse IL-6 ELISA kit (R&D Sys-
tems, Minneapolis, MN, USA).
Lipopolysaccharide Administration
Twenty mice were assigned to 4 experimental groups (5
animals/group). Dosing solutions of LPS were prepared in
PBS. Animals were dosed with 0.2 ml of 0.25 mg/ml LPS
or PBS by single intraperitoneal (i.p.) injection, observed
for clinical signs immediately post-treatment and prior to
sacrifice. Animals were fasted 2-hours prior to sacrifice.
Lung Harvest and Preparation of Homogenates
Post sacrifice, the left lung lobes were perfused with 10%
neutral-buffered formalin containing phosphatase inhibi-
tor cocktail (200 mM Sodium fluoride and 200 mM
Sodium pervanadate), placed in fixative for approxi-
mately 24 hours, stained for hematoxylin and eosin, and
evaluated by light microscopy. The right lung lobes were
snap-frozen (in liquid nitrogen) and stored at -80°C until
further analysis. The snap-frozen lungs were thawed,
weighed, transferred to different tubes on ice containing 1
ml of T-PER containing Complete Mini Protease Inhibitor
Cocktail tablets at a proportion of 1 tablet/10 ml of T-PER
stock reagent. The lung tissues were homogenized at 4°C.
Lung homogenates were centrifuged at 9,000 × g for 10
minutes at 4°C. Supernatants were transferred to clean
microcentrifuge tubes, frozen on dry ice and thawed on
ice. Total protein concentrations in the lung tissue
homogenates were determined using a BCA kit. Lung tis-
sue homogenates were diluted with 50% assay diluent
(provided in the Mouse Cytokine 10-Plex kit) and 50% T-
PER reagent to a final protein concentration of 500 μg/ml.Page 2 of 9
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The Mouse Cytokine 10-Plex kit reagents were used at
25°C according to the user manual to evaluate inter-
leukins -1β, -2, -4, 5, -6, -10, -12 [p40], -12 [p40] mono-
mer, and -12 [p70], IFNγ, GM-CSF and TNFα expression
patterns. Serial dilutions of the lyophilized standard were
prepared in assay diluent: T-PER reagent (1:1) and trans-
ferred to appropriate microtiter wells containing diluted
antibody-coated bead complexes and incubation buffer.
50 μl of each homogenate sample was transferred to
appropriate wells containing diluted antibody-coated
bead complexes and incubation buffer. Samples were
incubated for 2 hours. After washing with assay wash
buffer (200 μl/well), 100 μl diluted biotinylated second-
ary antibody was added to the appropriate wells and incu-
bated for 1 hour. After washing, 100 μl Streptavidin-
phycoerythrin was added to each well and incubated for
30 minutes. After a final wash, the plate was analyzed
using the Luminex 100 analyzer (Luminex Corp., Austin,
TX). Minimums of 400 events (beads) were collected for
each cytokine/sample and median fluorescence intensities
were obtained. Cytokine concentrations were calculated
based on standard curve data using MasterPlex™ QT Anal-
ysis version 2 (MiraiBio, Alameda, CA). The results are
expressed as mean ± SE (n = 5). Comparisons between all
groups for each respective cytokine were performed by
analysis of variances, choosing p < 0.05 as significant. For
IL-2 and GM-CSF, comparison between groups was per-
formed using a Wilcoxon signed rank test at each respec-
tive time point, with significance at p < 0.05. For IL-6, a
two-tailed t-test was applied at the 95% confidence level
(p < 0.05) at the 24-hour time point only. Analyses were
performed using Graphpad Prism version 4 (Graphpad
Software, San Diego, CA).
Antibody Array
Lung homogenate proteins were quantified using a BCA
kit. TranSignal™ qualitative measurement of tissue
cytokine expression was performed on lung homogenate
samples from the 24-hour control (n = 4) and LPS-treated
(n = 4) groups using the RayBio Mouse Cytokine Anti-
body Array kit according to the user manual. The signals
were detected using the ECL kit according to the user man-
ual, exposed on X-OMAT AR film and digitized using the
Duoscan HiD scanner (AGFA, Wilmington, MA).
ELISA
IL-6 levels were evaluated in lung tissue homogenates
from the 24-hour control (n = 4) and LPS-treated (n = 4)
groups using a mouse IL-6 ELISA kit according to the user
manual. Comparison between groups was performed




As shown in Figure 1, histopathologic evaluation of the
lungs revealed perivascular edema and an accumulation
of mixed cell infiltrates within blood and lymphatic ves-
sels, as well as in the adjacent interstitium at both 2-hours
(B) and 24-hours (D) following LPS treatment. A minimal
increase in the number of alveolar macrophages was also
observed in the 24-hour LPS-treated mice. One 24-hour
PBS-treated control mouse (C) had a focal incidental
mononuclear cell infiltrate present perivascularly within
the lung. No histopathologic findings were observed in
the lungs of 2-hour PBS-treated control mice (A).
Suspension Bead Array
As shown in Figure 2, statistically significant cytokine pro-
tein expression increases in lung tissue homogenates from
LPS-treated mice were noted for IL-6 (574-fold, p =
0.0425, B) and GM-CSF (8-fold, p = 0.0313, C) and a
decrease in IL-2 (1.3-fold, p = 0.0313, A) at 24-hours.
Antibody Array
Visual interpretation of the TranSignal™ RayBio Mouse
Cytokine Antibody Arrays (Figure 3A) suggests increased
expression of IL-6, IL-13 and L-selectin and macrophage
colony stimulating factor (MCSF) proteins and decreased
IL-2 protein in lung tissue homogenates from 24-hour
LPS-treated mice (C) compared to PBS-treated control
mice (B).
ELISA
Similar to the protein expression levels detected using sus-
pension bead array, statistically significant (p = 0.0313)
increased IL-6 protein expression was detected in lung tis-
sue homogenates from 24-hour LPS-treated mice using
ELISA (Figure 4).
Discussion
CD-1 mice are relatively sensitive to endotoxin and the
relative effects of endotoxin (specifically LPS) on lung
inflammation in CD-1 mice have been previously
described [2]. The purpose of the present study was to
investigate the feasibility of using suspension bead array
for detection of LPS (i.p. administration of 0.25 mg/ml)-
evoked changes in levels of cytokine protein expression
(at 2- and 24-hours post treatment) in mouse lung tissue
homogenates. Simultaneous detection of changes in lev-
els of lung cytokine proteins could prove useful during the
preclinical safety evaluation phase of compound develop-
ment.
LPS treatment was well tolerated in all animals; and there
were no adverse clinical observations in this study. LPS-
related histopathology changes were identified in the left
lung lobe in female CD-1 mice after treatment with LPSPage 3 of 9
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Representative histology of LPS-induced lung injury in CD-1 miceFigure 1
Representative histology of LPS-induced lung injury in CD-1 mice. H&E staining of left lung lobe from a female mouse 
following a single i.p. injection of 0.2 ml of 0.25 mg/ml LPS for 2 hours (B) or 24 hours (D) or PBS (vehicle) for 2 hours (A) or 
24 hours (C). No histopathologic findings were observed in the lungs of 2-hour PBS-treated control mice (A). One 24-hour 
PBS (vehicle)-treated control mouse (C) had a focal incidental mononuclear cell infiltrate present perivascularly within the lung. 
Perivascular edema and the accumulation of mixed cell infiltrates within blood and lymphatic vessels, as well as in the adjacent 
interstitium at both 2-hours (B) and 24-hours (D) following LPS treatment. A minimal increase in the number of alveolar mac-
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The alignment of the 22 analytes on the RayBio Mouse Cytokine Antibody ArrayFigure 2
The alignment of the 22 analytes on the RayBio Mouse Cytokine Antibody Array. Abbreviations: bFGF: basic 
fibroblast growth factor; CD: cluster of differentiation; GCSF: granulocye colony stimulating factor; GM-CSF: granulocyte/mac-
rophage-colony stimulating factor; IFN: interferon; IL: interleukin; MCP: monocytes-chemoattractant protein; M-CSF: macro-
phage-colony stimulating factor; MIP: macrophage inflammatory protein; RANTES: regulated on activation, normal T-cell 
expressed and secreted; TNF: tumor necrosis factor; VEGF: vascular endothelial cell growth factor. Quantitative levels of 
cytokine protein concentrations (pg/ml) in lung homogenates from CD-1 mice at both 2- and 24-hours after i.p. administration 
of LPS or PBS vehicle (control) using suspension bead array. Significant levels of cytokine protein expression increases in lung 
homogenates from LPS-treated mice were noted for IL-6 (B) and GM-CSF (C) and a significant decrease in IL-2 (A) at 24-








































Journal of Inflammation 2006, 3:15 http://www.journal-inflammation.com/content/3/1/15(0.25 mg/ml) for both 2- and 24-hours. The inflamma-
tory changes were characterized by perivascular edema
and the accumulation of mixed cell infiltrates within
blood and lymphatic vessels, as well as in the adjacent
interstitium at both 2-hours and 24-hours following LPS
treatment. A minimal increase in the number of alveolar
macrophages was also observed in the 24-hour LPS-
Representative qualitative levels of cytokine protein expressions in lung homogenates from CD-1 mice at 24-hours after i.p. administration of LPS or PBS vehicle (control) using antibody arraysFigure 3
Representative qualitative levels of cytokine protein expressions in lung homogenates from CD-1 mice at 24-
hours after i.p. administration of LPS or PBS vehicle (control) using antibody arrays. The array key represents the 
location of each antibody in duplicate on the membrane (A). Increased protein expression levels of IL-6 and IL-13 and L-selec-
tin and decreased IL-2 were detected in lung homogenates from LPS-treated (24-hour) mice (C) but not in lung homogenates 
from PBS vehicle (control)-treated (24-hour) animals (B). N = 4/treatment group.
A.
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Quantitative level of IL-6 protein expression in lung homogenates from CD-1 mice at 24-hours after i.p. administration of LPS or PBS vehicle (control) using ELISAFigure 4
Quantitative level of IL-6 protein expression in lung homogenates from CD-1 mice at 24-hours after i.p. 
administration of LPS or PBS vehicle (control) using ELISA. Results are represented as the mean (pg/ml) ± SEM. * : P 
























Journal of Inflammation 2006, 3:15 http://www.journal-inflammation.com/content/3/1/15treated mice. No histopathology findings were observed
in the lungs of 2-hour PBS-treated control mice.
In the present study, among the 24-hour LPS-treated ani-
mals, increased IL-6 (574-fold) and GM-CSF (8-fold) and
decreased IL-2 (1.3-fold) protein concentrations in lung
homogenates were detected using suspension bead array.
Previously, we reported observations of statistically signif-
icant increases in CD-1 mouse plasma IL-6 protein expres-
sion at both 2- and 24-hours post LPS treatment and GM-
CSF protein expression at 2-hours post LPS treatment [4].
Suspension bead array-detectable changes in lung
homogenate levels of IL-2, -6 and GM-CSF protein expres-
sion 24-hours following LPS treatment correlated with
qualitative protein expression profile data (i.e., as low as
10 pg/ml of IL-2) detected using antibody array. In this
study, antibody arrays findings suggested significantly
increased expression of IL-6 and -13 and L-selectin pro-
teins and significantly decreased IL-2 protein in lung
homogenates from 24-hour LPS-treated mice. Similar to
the protein expression levels detected using suspension
bead array, significantly increased IL-6 protein expression
was detected in lung homogenates from 24-hour LPS-
treated mice using ELISA.
LPS exerts adjuvant effects on macrophages, resulting in
an inflammatory cascade defined by early production of
TNFα followed by subsequent production of IL-1, IL-6 [8]
and MIP-2 [2]. The production of TNFα by macrophages
and the recruitment of inflammatory cells are regulated by
T cells. High dose (1000 μg/ml) LPS exposure causes acti-
vation of both T cells and macrophages, while low dose
(100 μg/ml) treatment evokes activation of macrophages
only [8]. Perivascular edema and accumulation of mixed
cell infiltrates in the lung is typical of lung inflammatory
responses [2]. In the present study, the LPS dose of 250
μg/ml evoked lung perivascular edema, accumulation of
mixed cell infiltrates within blood and lymphatic vessels
and in the adjacent interstitium. These changes parallel
the significantly increased levels of IL-6 and GM-CSF in
lung tissue homogenate from LPS-treated mice versus
controls. Only a minimal increase in the number of alve-
olar macrophages was observed 24-hours post LPS treat-
ment, which also corroborates with the "minimally"
elevated levels of macrophage-origin cytokines (IL-6 and
GM-CSF) in lung tissue homogenates. Taken together, the
enhanced cytokine levels detected in lung tissue homoge-
nates suggest an increased local cytokine production in
the lungs by LPS-activated macrophages. Alternatively,
histopathology changes observed in the LPS-treated mice
may reflect local effects due to the highly elevated circulat-
ing cytokines (TNFα, IFNγ, GM-CSF, IL-1β, IL-5, IL-6, IL-
10, IL-12), which were reported previously for these ani-
mals [4]. Circulating cytokine levels were log-folds higher
than those observed for the lung tissue homogenates,
which may indicate a tissue dilution effect and/or a tissue
sampling phenomenon, since the histopathology changes
were multi-focal and not diffusely distributed. Similarly,
the decrease in IL-2 expression in lung tissue homoge-
nates following LPS treatment could possibly be due to
tissue dilution effect and/or a tissue sampling phenome-
non, but requires further investigation.
In summary, we found that a single i.p. administration of
LPS at 0.25 mg/ml yielded significantly increased IL-6 and
GM-CSF proteins and decreased IL-2 protein expression in
lung tissue homogenates using suspension bead array.
These findings correlated with cytokine protein expres-
sion profiles detected using antibody array and were con-
firmed using conventional ELISA (IL-6 protein
concentrations).
Conclusion
Overall, the present study shows that suspension bead
array is a feasible method for detecting changes in
cytokine protein expression in mouse lung tissue
homogenates.
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